InvestorsHub Logo
Followers 61
Posts 7517
Boards Moderated 2
Alias Born 02/10/2010

Re: NewMoney post# 117720

Wednesday, 02/10/2016 3:55:19 PM

Wednesday, February 10, 2016 3:55:19 PM

Post# of 146196

They keep saying they have enough cash to get a drug to human trials.


Because they do,.... unlike many 'biowrecks' this particular company has no significant short to medium-term liquidity issues. One of the reasons I think they are in a pretty good place right now.

They just never actually do it.


Yet,.... but things are moving forward quite nicely now,....

That's failure to perform in my book and explains the stock price.


On this point we are at least partially in agreement. However, it also means that once performance is no longer viewed as 'the issue',... they are in a very good place to move up.

Solid cash position & with no need to raise additional capital for at least a year, possibly two. Also not that much debt,...

Two drug candidates leading the way, with at least one with high probability of hitting clinical testing before the end of 2016.

Own their own fully equipped manufacturing facility with trained staff.

Gotta love the potential with the next year or two,.... although it's going to be a slow slog through 2016 to get there.

But I remain a patient (and well positioned) guy!

“The two most powerful warriors are patience and time.”
- Leo Nikolaevich Tolstoy

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News